Prevalence and characteristics of misdiagnosed adult-onset type 1 diabetes mellitus in Thai people by random plasma C-peptide testing

Shields, 2010, Maturity onset diabetes of the young (MODY): how many cases are we missing?, Diabetologia, 53, 2504, 10.1007/s00125-010-1799-4

Porter, 2006, Asian MODY: are we missing an important diagnosis?, Diabet. Med., 23, 1257, 10.1111/j.1464-5491.2006.01958.x

Riddle, 2020, Monogenic diabetes: from genetic insights to population-based precision in care. Reflections from a diabetes care editors' expert forum, Diabetes Care, 43, 3117, 10.2337/dci20-0065

Yu, 2019, Residual β cell function and monogenic variants in long-duration type 1 diabetes patients, J. Clin. Invest., 129, 3252, 10.1172/JCI127397

Hattersley, 2018, ISPAD Clinical Practice Consensus Guidelines 2018: the diagnosis and management of monogenic diabetes in children and adolescents, Pediatr. Diabetes, 19, 47, 10.1111/pedi.12772

Park, 2017, Clinical heterogeneity of type 1 diabetes (T1D) found in Asia, Diabetes Metab. Res. Rev., 33, 10.1002/dmrr.2907

Ross, 2022, The prevalence of islet autoantibodies in children and adolescents with type 1 diabetes mellitus: a global scoping review, Front. Endocrinol., 13, 10.3389/fendo.2022.815703

Holt, 2021, The management of type 1 diabetes in adults. A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD), Diabetes Care, 44, 2589, 10.2337/dci21-0043

Lambert, 2003, Identifying hepatic nuclear factor 1a mutations in children and young adults with a clinical diagnosis of type 1 diabetes, Diabetes Care, 2, 333, 10.2337/diacare.26.2.333

Gandica, 2015, Identifying monogenic diabetes in a pediatric cohort with presumed type 1 diabetes, Pediatr. Diabetes, 16, 227, 10.1111/pedi.12150

Foteinopoulou, 2021, Impact of routine clinic measurement of serum C-peptide in people with a clinician diagnosis of type 1 diabetes, Diabet. Med., 38, 10.1111/dme.14449

Besser, 2013, Lessons from the mixed‐meal tolerance test: use of 90‐minute and fasting C‐peptide in pediatric diabetes, Diabetes Care, 36, 195‐201, 10.2337/dc12-0836

Thanabalasingham, 2012, Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young, Diabetes Care, 35, 1206, 10.2337/dc11-1243

Jones, 2013, The clinical utility of C-peptide measurement in the care of patients with diabetes, Diabet. Med., 30, 803, 10.1111/dme.12159

Shepherd, 2016, Systematic population screening, using biomarkers and genetic testing, identifies 2.5% of the U.K. pediatric diabetes population with monogenic diabetes, Diabetes Care, 39, 1879, 10.2337/dc16-0645

Johansson, 2017, Targeted next generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry, Diabetologia, 60, 625, 10.1007/s00125-016-4167-1

Urrutia, 2019, Negative autoimmunity in a Spanish pediatric cohort suspected of type 1 diabetes, could it be monogenic diabetes?, PLoS One, 14, 10.1371/journal.pone.0220634

Delvecchio, 2017, Monogenic diabetes accounts for 6.3% of cases referred to 15 Italian pediatric diabetes centers during 2007 to 2012, J. Clin. Endocrinol. Metab., 102, 1826, 10.1210/jc.2016-2490

Besser, 2011, Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes, Diabetes Care, 34, 286, 10.2337/dc10-1293

Yilmaz Agladioglu, 2015, Urinary C-Peptide/Creatinine Ratio can distinguish maturity-onset diabetes of the young from type 1 diabetes in children and adolescents: a single-center experience, Hor. Res. Paediatr., 84, 54, 10.1159/000375410

Ozsu, 2018, Maturity onset diabetes of the young due to glucokinase, HNF1-A, HNF1-B, and HNF4-A Mutations in a cohort of Turkish children diagnosed as type 1 diabetes mellitus, Hor. Res. Paediatr., 90, 257, 10.1159/000494431

Petruzelkova, 2016, Substantial proportion of MODY among multiplex families participating in a Type 1 diabetes prediction, Diabet. Med., 33, 1712, 10.1111/dme.13043

Balasubramanyam, 2008, Syndromes of ketosis-prone diabetes mellitus, Endocr. Rev., 29, 292, 10.1210/er.2007-0026

Berger, 2000, Random C-peptide in the classification of diabetes, Scand. J. Clin. Lab. Invest., 60, 687, 10.1080/00365510050216411

Hope, 2016, Random non-fasting C-peptide: bringing robust assessment of endogenous insulin secretion to the clinic, Diabet. Med., 33, 1554, 10.1111/dme.13142

Shields, 2017, UNITED study team. Population-based assessment of a biomarker-based screening pathway to aid diagnosis of monogenic diabetes in young-onset patients, Diabetes Care, 40, 1017, 10.2337/dc17-0224